1459 CLINICAL AND PATHOLOGIC FEATURES OF PROSTATE CANCER WITH PROSTATIC-SPECIFIC ANTIGEN (PSA) LESS THAN 2.5 NG/ML: A STUDY OF 209 CASES
Quoc‐Dien Trinh(Harvard University), Nilesh Gupta(Henry Ford Health System), Leonardo Roquero(Johns Hopkins University), Khurshid R. Ghani(University of Michigan), Shyam Sukukumar, Wooju Jeong(Henry Ford Hospital), Mani Menon(Henry Ford Hospital), Mireya Díaz(American Urological Association), Oleksandr N. Kryvenko(University of Miami)
Cited by 0
Related Papers
Evaluation and Treatment of Cryptorchidism: AUA Guideline
|The Journal of Urology|2014|508
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
|Modern Pathology|2014|227
ERG gene rearrangements are common in prostatic small cell carcinomas
|Modern Pathology|2011|219